Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.64 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.64 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.47 |
| ▸ | TGM2 | P21980 | 5/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2032859 | 0.86 | EGLN1 (0.61) | EGLN1MAPK1EPHX1FAAHKDM4E | |
| SCHEMBL11596790 | 0.86 | EGLN1 (0.61) | EGLN1MAPK1EPHX1FAAHKDM4E | |
| SCHEMBL13552393 | 0.84 | EGLN1 (0.63) | EGLN1MAPK1ALDH1A1GAAEPHX1 | |
| SCHEMBL22382274 | 0.83 | ZDHHC20 (0.69) | ZDHHC20ZDHHC2TGM2TSHREPHX1 | |
| SCHEMBL18808391 | 0.83 | ZDHHC20 (0.53) | ZDHHC20ZDHHC2TGM2MAPK1ALDH1A1 | |
| SCHEMBL11793603 | 0.82 | ZDHHC20 (0.62) | ZDHHC20ZDHHC2TGM2ALDH1A1TSHR | |
| SCHEMBL11408936 | 0.80 | EPHX1 (0.57) | ZDHHC20ZDHHC2EGLN1TSHREPHX1 | |
| SCHEMBL2487820 | 0.80 | EPHX1 (0.57) | ZDHHC20ZDHHC2EGLN1TSHREPHX1 | |
| SCHEMBL15682714 | 0.80 | EPHX1 (0.57) | ZDHHC20ZDHHC2EGLN1TSHREPHX1 | |
| SCHEMBL270209 | 0.80 | ZDHHC20 (0.79) | ZDHHC20ZDHHC2TGM2MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11547674-B2 | Protein-polymer hybrid biomaterials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-01-10 | — | — | US | disclosed |
| US-20200054574-A1 | PROTEIN-POLYMER HYBRID BIOMATERIALS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200054574-A1 | PROTEIN-POLYMER HYBRID BIOMATERIALS | LDHA, LDHB, STIP1 | ZDHHC20 2381/4885ZDHHC2 2641/4885EGLN1 323/4885 |
| US-11547674-B2 | Protein-polymer hybrid biomaterials | LDHA, LDHB, STIP1 | ZDHHC20 2381/4885ZDHHC2 2641/4885EGLN1 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.